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Background: This study aims to evaluate whether the uptake difference by the condyles evaluated using single 
photon emission computed tomography (SPECT) examination is useful for predicting the activity of the feature 
and the advance of this pathology.
Material and Methods: An observational and prospective study has been carried out on nine patients affected by 
unilateral condylar hyperplasia (UCH) with complete bone maturation, with a follow-up over 18 months. At the 
beginning of the study, a test-battery was conducted including dental casts, articular examination, teleradiography 
and cephalometry, computed tomography and SPECT, creating two groups of patients from a difference in uptake 
between both condyles greater than 10% over the follow-up period. Evolution of data obtained with the rest of the 
diagnostic tests were compared to confirm UCH activity predicted by SPECT.
Results: The comparison of both groups did not show hardly any significant differences, with little clinical signifi-
cance. Deviation of the mandibular line, the size of the branches or condyles behaved similarly in both study groups.
Conclusions: From the data obtained in our study, we can conclude that the use of the difference in uptake be-
tween both condyles by applying the SPECT technique is not a valid approach for predicting clinical activity 
in cases of UCH.
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phy, condylar hyperplasia.
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Introduction
During the development of the facial skeleton, the man-
dibular condyles need to undergo similar and coordi-
nated growth for facial symmetry and proper dental oc-
clusion to occur. Said growth ends at the age of 15 years 
in women and at 18 years in men (1).
Condylar hyperplasia is a pathological condition char-
acterised by abnormal and progressive growth of man-
dibular condylar cartilage (1). It is due to a non-neo-
plastic increase in the number of normal bone cells (1). 
It is infrequent, and in the majority of cases, it presents 
unilaterally and is associated with facial and mandibu-
lar asymmetry. It shows no preference for sex, race or 
altered laterality (1).
The aetiology of unilateral condylar hyperplasia 
(UCH) is uncertain and controversial, being con-
sidered a reactive process to a stimulus which is not 
known with any accuracy; however, we may assume 
that there are hormonal factors (somatomedin, growth 
factors such as IGF-1), as well as biomechanical (trau-
ma), vascular, neoplastic (osteoma, osteochondroma 
and chondroma) or infectious which are involved in its 
development (2-4).
Clinical findings of UCH are facial and mandibular 
asymmetry, occlusal disorders with open or crossed 
bite, bone compensations and/or dental ones with over-
eruption and laterognathia, etc. Likewise, it is associ-
ated with episodes of pain, blockage or dislocation of 
the temporomandibular joint (TMJ) (1,5,6).
There are a multitude of diagnostic methods for de-
tecting patients with condylar hyperplasia, the man-
agement of several of these methods being the instru-
ment required for identifying the type of condylar 
hyperplasia and the facial or occlusal change present 
in the patient (7-9).
Although the signs and symptoms may lead to a correct 
diagnosis, help needs to be sought using imaging and 
cephalometric measurements to obtain more informa-
tion, since the patient may remain in an active phase, 
with mandibular condylar growth, or in an inactive or 
stationary phase, where condylar growth is halted (1-7).
Besides cephalometric methods for evaluating facial 
asymmetry, Single Photon Emission Computed Tomog-
raphy (SPECT) has been the diagnostic method chosen 
up to now for the definitive diagnosis of UCH activity. 
SPECT is an imaging method based on the injection 
of phosphates marked with radionuclides providing a 
functional image which shows the metabolic response 
of the object being evaluated. The amount of trace 
material is controlled by the level of metabolic activ-
ity and/or blood supply in the region emitting radiation 
which is detected by gamma cameras. SPECT is able to 
enable three-dimensional reconstructions, it combines a 
graphic and numerical representation of the pixel count, 
and is an excellent means for quantifying and compar-
ing osteoblast activity in condyles and drawing up a 
suitable treatment plan. A variant of the technique is 
SPECT/CT where it is associated with the implementa-
tion of Computed Tomography for measuring structures 
of interest (7-19).
Until now, SPECT has been the diagnostic method of 
choice for confirming UCH activity. For confirming 
said activity, a difference of more than 10% uptake be-
tween condyles has been taken as a reference (14). How-
ever, in the light of various publications taken from the 
literature (16,20), it is not clear that the use of SPECT is 
the ideal radiological method for establishing said diag-
nosis and a certain degree of controversy is maintained 
in this statement.
This point within UCH management is essential, be-
cause once the diagnosis of UCH in a patient has been 
made, what the development of condylar and mandibu-
lar growth will be is unknown and, consequently, how 
it will affect the facial and occlusal appearance of the 
patient over time (20). It is for this reason that diagnosis 
in patients with active UCH would enable its clinical de-
velopment to be foreseen, and it would enable the pos-
sibility of implementing early treatment thus avoiding 
the emergence of more serious deformities over time.
The study aims to determine the reliability of the use 
of Single Photon Emission Computed Tomography 
(SPECT) in the diagnosis of unilateral condylar hyper-
plasia activity focusing on the correct forecast of the 
possible development and worsening of the asymmetry 
diagnosed.
The study hypothesis is that, within the population diag-
nosed with UCH, the existence of an uptake difference 
greater than 10% between both condyles corresponds 
to active hyperplasia which must be endorsed clinically 
within a prudential period which in this study has been 
held at 18 months.
The hypothesis is important because many clinical de-
cisions are taken bearing in mind or employing this con-
cept of active hyperplasia based on this test (13).
Material and Methods
- Study design
The design we have used for implementing the SPECT 
analysis as a diagnostic method of unilateral condylar 
hyperplasia activity has been an observational, analytic 
and prospective study on nine patients suffering from 
unilateral condylar hyperplasia with complete bone 
maturation (in accordance with the extended Björk 
stages) (21).
This study was approved by the Ethics Committee of 
the Virgen del Rocío University Hospital, undertaken 
between January 2011 and December 2016 and has been 
financed by the Andalusian Regional Department of 
Health.
Before participation, the purpose and procedures were 
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explained in detail to all the volunteers, and all the par-
ticipants gave their informed consent in writing in ac-
cordance with the Helsinki declaration. The study was 
designed, implemented, analysed and reported in accor-
dance with the “Good Clinical Practice” standards.
- Inclusion and exclusion criteria
The inclusion criteria for patients in this study have 
been: patients with unilateral condylar hyperplasia. Di-
agnosis was carried out based on the following clinical 
and x-ray criteria: patients with clear facial and man-
dibular asymmetry identified by two maxillofacial sur-
geons, together with differences in shape and volume 
between both condyles, confirmed using a CT scan (22); 
patient, or in the case of an under-age patient, father, 
mother or guardian who has been informed by the re-
searcher of the aims, risks and benefits of the study, as 
well as the corresponding obligations and whose con-
sent for participating in the study has been given in 
writing; patient, or in the case of an under-age patient, 
father mother or guardian who understands the need for 
cooperating throughout the duration of the study.
Exclusion criteria for patients in this study have been: 
Patient without unilateral condylar hyperplasia; patient 
with a history of trauma, infection or neoplasia in any 
temporomandibular joint; patient with general bone 
syndrome; patient with x-ray signs characteristic of 
another condylar pathology; patient treated previously 
with dental facial orthopaedic or orthognathic surgery; 
patient with a physical, mental, psychological or lin-
guistic pathology which may limit the understanding or 
adherence to the study.
- Study development and evaluation of the participants
All patients included in the study underwent an ex-
haustive examination at the beginning of the study and 
18 months later, in an attempt to identify any change 
in the growth of the structures studied. Said tests were 
as follows.
Plaster casts of the upper and lower arcade and bite reg-
istration for analysis of deviation of the dental midline 
(mm) were taken. A detailed clinical examination of the 
TMJ in which ranges of mandibular mobility (maximum 
opening, laterality and protrusion) were observed for 
which we used Therabite® motion scales (Atos Medical 
Spain SL, Spain) and expressed measurements in mm.
Likewise, subjective pain was present in the various 
muscle groups (temporal, masseter, internal pterygoid, 
lateral pterygoid and sternocleidomastoid) and the left 
and right TMJ itself was examined. The existence of 
opening and closing snaps in both TMJs.
Lateral and frontal teleradiography of the cranium was 
carried out using an analogue Strato 2000 Panoramic 
X-Ray unit by Villa Sistemi Medicali S.P.A (Milan, 
Italy). It was carried out at a focal distance from the 
plate of 1.5m., Penetration (Kv) range between 60 and 
90 KV and the intensity of the x-rays was between 6 and 
15mA., parameters which are regulated depending on 
the size of the cranium to be studied. Likewise, the ap-
paratus consisted of a system of filters for the soft parts 
of the anterior side of the face (nose, lips and chin on the 
output tube of the x-ray device in order to mitigate the 
amount of radiation they receive and to be able to see 
them together with the harder tissues (bone structures) 
on the plate itself).
After obtaining the x-ray tests indicated above, various 
cephalometric analyses were carried out to determine 
UCH using orthodontic measurement parameters.
Firstly, Ricketts frontal cephalometric analysis was car-
ried out. Ricketts frontal cephalometric analysis is cur-
rently used in the American Institute for Bioprogressive 
Education, it is based on classic frontal cephalometric 
analysis, although with a different order, and it includes 
some new measurements. The same structures of the 
classic analysis must be represented and besides the first 
lower premolars and the mid-palatal suture: the points 
and planes are the same. This study includes two fields 
of study, the skeletal problem and the dental problem (6).
Secondly, a Jarabak lateral cephalometric analysis was 
performed. Jarabak analysis is useful to determine 
qualitative and quantitative growth characteristics, that 
is, growth direction and potential. Furthermore, it con-
tributes to a better definition of facial biotypology. Jara-
bak’s polygon is efficient at detecting the reaction they 
will have compared to therapeutic procedures for those 
patients belonging to not very well-defined biotypes. 
For Jarabak, the basis of diagnosis is to build up the 
areas of overlap essential for case planning and its sub-
sequent evaluation, enabling better vision of the case 
to be obtained with the fewest cephalometric measure-
ments (6).
Both Ricketts frontal cephalometry and Jarabak lateral 
cephalometry were performed using Dolphin software 
(Dolphin Imaging and Management Solutions, Califor-
nia, USA).
A SPECT-CAT scan was carried out in DICOM format. 
To study the three-dimensional SPECT-CAT tomo-
graphic x-ray images, we used VirSSPA software (12), 
a virtual reality program which generates 3D models 
developed by the Andalusian Regional Government 
(Spain). The presence or absence of unilateral condylar 
hyperplasia was evaluated using a volumetric bilateral 
condylar and bilateral mandibular study (9). Selecting 
the cranial bone tissue using the seed segmentation 
method, we analysed the following parameters: Right 
and left linear mandibular condyle length (cm), right 
and left linear ascending branch mandibular length 
(cm), right and left surface mandibular hemibody length 
(cm), right and left linear mandibular hemibody length 
(cm), right and left mandibular condyle volume (cc), 
right and left ascending branch mandibular volume (cc) 
and right and left mandibular hemibody volume (cc).
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Finally, a SPECT scintigraphy of bilateral TMJ was car-
ried out in two stages and a Selective Bone SPECT-CT 
with an analysis of uptake percentage between mandib-
ular condyles using mean region of interest (ROI). The 
radiopharmaceutical used was Tc99m in the form of 
hydroxymethylene diphosphonate (HDP) at an intrave-
nous dose of 22 mCi. Instrumentation was implemented 
using a Siemens Symbia T6 gamma camera with a low 
energy and high-resolution collimator (Siemens AG, 
Germany). The estimated effective dose was 4.1 mSv 
for an administered dose of 740 MBg. The uptake dif-
ferential between the right condyle and the left condyle 
of the TMJ was analysed to be able to examine in this 
way the presence of active unilateral condylar over-
growth and to be able to establish, using this parameter, 
the study groups to carry out the study in question.
Two groups of studies were determined depending on 
the uptake difference between both condyles in accor-
dance with the criteria delivered by Saridin et al. (14), 
establishing as a study group those patients with an up-
take difference between both condyles greater than 10% 
maintained for the 18-month follow-up, and as the con-
trol group, those patients with a difference below 10% 
between uptake between condyles. After taking this 
reference, we established our study groups, five patients 
were selected for the experimental group compared to 
four patients for the control group.
- Statistics
Statistically, final data were taken and they were com-
pared with the initial ones from the diagnostic tests car-
ried out, giving rise to values which summarise the de-
velopment of both groups over the 18-month follow-up 
period. The qualitative variables (Yes/No) were quanti-
fied by coding as a 0 value the No value and with the 1 
value the Yes value, in order to make the comparison of 
said variables easier. Said values were compared using 
a non-parametric test (Mann-Whitney U test). A p<0.05 
value was assumed to be significant.
Results
The average age at the start of the study was 19.89 ± 7.76 
years. There was a total of four men compared to five 
women in the participants in this study. Data obtained 
from the SPECT determined that five participants be-
longed to the study group (uptake difference greater 
than 10% between condyles) compared to four in the 
control group (uptake difference less than 10% between 
condyles) (Table 1).
Regarding the data, we can see in Table 2, both the data 
relating to the displacement of the lower midline and 
those relating to the joint examination did not show sig-
nificant differences between both groups. What is more, 
in fact, in some variables, such as displacement of the 
lower midline, it is greater in the control group than in 
the experimental one.
In respect of the measurements obtained from the ceph-
alometric measurements on Ricketts frontal cephalom-
etry, we can focus on the maxillo-mandibular midline, 
(Maxillo-Mand Midline (mm)), as the most useful data 
in the control of these patients because it analyses the 
deviation of the chin compared to the upper maxilla. 
The data provided by this measurement in the develop-
ment of both groups is not statistically significant. What 
is more, there is greater variation in the control group 
than in the experimental one.
In the Jarabak lateral cephalometry one of the most 
important measurements is the height of the ascending 
branch (Ramus Height (Ar-Go) (mm)) and the posterior 
face height ((Posterior Face Height (SGo) (mm)). In both 
measurements, the behaviour of both groups is similar, 
of course, without reaching statistically significant dif-
ferences between them (Table 2).
Finally, the measurements on length of the mandibular 
branch or the condylar volume using CBCT in the initial 
and final stages of the study in patients in both groups, 
neither variations nor different behaviours were identi-
fied between both groups of patients (Table 2).
Case 1 2 3 4 5 6 7 8 9
Age at start of study 17 24 26 9 11 31 27 13 21
Sex M M F M F F F M F
Right Initial SPECT Uptake 56.8 40 41.5 63.3 52.4 57 50.5 45.4 46.6
Left Initial SPECT Uptake 43.2 60 58.5 36.7 47.6 43 49.5 56.4 53.4
Difference in Final Right v Left SPECT Uptake 13.6 -20 -17 26.6 4.8 14 1 -11 -6.8
Final Right SPECT Uptake 52 46.3 52 60 61 53 52 51.8 39
Final Left SPECT Uptake 48 53.7 42 40 39 47 48 48.2 61
Difference in Final Right v Left SPECT Uptake 4 -7.4 10 20 22 6 4 3.6 -22
Mean of differences in Initial-Final Right vs 
Left SPECT Uptake
8.8 -13.7 -3.5 23.3 13.4 10 2.5 -3.7 -14.4
Group allocation 2 1 2 1 1 1 2 2 1
Table 1: Characteristics of the patients being studied, uptake per condyle at the start of the study and at 18-month follow-up, differences between 
both initial and final uptakes and difference of average uptake between both condyles during the 18-month follow-up, which gave rise to the 
allocation to the study group (> than 10%) or control group (< than 10%) (Group 1 – Study / Group 2 – Control).
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0.00 ± 0.00 -0.38 ± 0.47 NS
 (mm)
Variables mea-
sured in joint 
examination
Mobility of TMJ
Maximum opening (mm) -2.20 ± 5.54 -1.75 ± 0.95 NS
Right laterality (mm) 2.00 ± 4.63 -0.25  ± 4.57 NS
Left laterality (mm) 1.00 ± 1.87 1.25 ± 2.87 NS
Protrusive (mm) -1.00 ± 1.22 0.75 ± 2.21 NS
Mandibular deviation 
in opening (Alloca-
tion of values: 0 No 
- 1 Yes)
Right 0.00 ± 0.00 -0.25 ± 0.50 NS
Left 0.00 ± 0.00 -0.25 ± 0.50 NS
Pain in Right TMJ 
(Allocation of values: 
0 No - 1 Yes)
TMJ -0.20 ± 0.44 0.00 ± 0.00 NS
Temporal 0.00 ± 0.70 0.00 ± 0.00 NS
Masseter 0.00 ± 0.00 0.00 ± 0.00 NS
Internal pterygoid 0.20 ± 0.44 0.00 ± 0.00 NS
Lateral pterygoid -0.20 ± 0.44 -0.25 ± 0.50 NS
SCM 0.20 ± 0.44 0.00 ± 0.00 NS
Pain in Left TMJ (Al-
location of values: 0 
No - 1 Yes)
TMJ 0.00 ± 0.00 0.25 ± 0.50 NS
Temporal 0.00 ± 0.00 -0.25 ± 0.50 NS
Masseter 0.20 ± 0.83 0.00 ± 0.00 NS
Internal pterygoid -0.20 ± 0.44 0.00 ± 0.00 NS
Lateral pterygoid 0.00 ± 0.70 0.25 ± 0.50 NS
SCM 0.20 ± 0.44 0.00 ± 0.00 NS
Right Snap (Alloca-
tion of values: 0 No 
- 1 Yes)
Start of opening 0.00 ± 0.70 0.00 ± 0.00 NS
Middle of opening 0.00 ± 0.00 0.25 ± 0.50 NS
End of opening 0.00 ± 0.00 -0.50 ± 0.57 NS
Start of closing -0.20 ± 0.44 0.00 ± 0.00 NS
Middle of closing 0.00 ± 0.00 0.00 ± 0.00 NS
End of closing 0.20 ± 0.44 0.00 ± 0.81 NS
Left Snap (Allocation 
of values: 0 No - 1 
Yes)
Start of opening -0.40 ± 0.54 -0.25 ± 0.50 NS
Middle of opening 0.00 ± 0.00 0.25 ± 0.50 NS
End of opening 0.20 ± 0.44 0.00 ± 0.00 NS
Start of closing 0.00 ± 0.00 -0.25 ± 0.50 NS
Middle of closing 0.00 ± 0.00 0.00 ± 0.00 NS
End of closing -0.20 ± 0.44 0.00 ± 0.81 NS
Measurements 
carried out 





Frontal Convexity. Left (mm) 1.00 ± 2.68 0.32 ± 0.61 NS
Frontal Convexity. Right (mm) 1.50 ± 2.44 -0.55 ± 2.31 NS
Maxillo-Mand Midline (mm) 0.42 ± 5.58 1.45 ± 1.98 NS
Craniofacial relation Postural Symmetry (°) 5.00 ± 2.29 -2.97 ± 5.46 0,02
Deep skeletal 
structure
Nasal Width (mm) -1.10 ± 1.19 0.28 ± 3.10 NS
Maxillary Width (mm) -1.42 ± 1.41 0.98 ± 3.71 NS
Mandibular Width (mm) 2.46 ± 3.60 0.62 ± 2.92 NS
Cranial base / 




Saddle/Sella Angle (SN-Ar) (º) 2.64 ± 4.79 0.80 ± 1.72 NS
Anterior Cranial Base (SN) (mm) -0.82 ± 1.80 -0.17 ± 1.08 NS
Posterior Cranial Base (S-Ar) (mm) -1.52 ± 0.80 -1.47 ± 0.74 NS
Mandible
Gonial/Jaw Angle (Ar-Go-Me) (º) -2.06 ± 2.30 -4.42 ± 9.21 NS
Mandibular Body Length (Go-Gn)(mm) 0.36 ± 1.17 3.12 ± 5.30 NS
Upper Gonial Angle (Ar-Go-Na) (º) -0.92 ± 1.38 -1.67 ± 5.95 NS
Lower Gonial Angle (Na-Go-Me) (º) -1.16 ± 1.48 -2.80 ± 3.70 NS
Ramus Height (Ar-Go) (mm) 0.78 ± 2.79 -0.45 ± 3.32 NS
Table 2: Change in controlled variables during the 18-month follow-up period of the study (Postural symmetry, the only measurement for the 
craniofacial relation, is the difference in angles (left and right) formed by a plane from the zygomatic suture to the antegonion and the antegonion 
to the zygomatic arch).
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 Measurements 
carried out 




SNA (º) -0.28 ± 1.83 -1.05 ± 1.85 NS
SNB (º) -0.12 ± 1.07 -0.25 ± 1.18 NS
ANB (º) -0.14 ± 1.72 -0.80 ± 2.23 NS
Convexity (NA-APo) (º) 0.24 ± 3.14 -2.57 ± 4.90 NS
Cranial base / 
mandible
Articular Angle (º) -0.82 ± 5.28 2.30 ± 9.26 NS
Sum of Angles (Jarabak) (º) -0.24 ± 1.63 -1.30 ± 1.60 NS
Jarabak Anterior Ratio (x100) -1.30 ± 2.46 -3.87 ± 6.44 NS
MP - SN (º) -0.24 ± 1.63 -1.30 ± 1.60 NS
Nasion-Gonion Length (mm) -0.42 ± 2.29 0.27 ± 2.71 NS
Y-Axis Length (mm) -1.90 ± 3.01 -0.90 ± 1.82 NS
Facial Plane to SN (SN-NPog) (º) -0.40 ± 1.02 0.20 ± 1.91 NS
Posterior Face Height (SGo) (mm) -1.00 ± 2.02 -0.97 ± 1.92 NS
Anterior Face Height (NaMe) (mm) -1.34 ± 3.26 -1.37 ± 1.81 NS
P-A Face Height (S-Go/N-Me) (%) -0.20 ± 1.09 -0.07 ± 2.18 NS
Y-Axis (SGn-SN) (º) 0.32 ± 1.51 -0.37 ± 1.96 NS
Soft tissue
Lower Lip to E-Plane (mm) -0.44 ± 1.58 0.30 ± 1.95 NS




Right 0.17 ± 0.20 0.06 ± 0.12 NS
Left 0.10 ± 0.17 -0.02 ± 0.12 NS
Leng. Ascending 
Branch (cm)
Right -0.26 ± 0.48 -0.13 ± 0.19 NS
Left -0.08 ± 0.37 -0.05 ± 0.20 NS
Leng. Mand. Surface 
Body (cm)
Right -0.18 ± 0.20 0.09 ± 0.06 NS
Left -0.18 ± 0.33 0.01 ± 0.10 NS
Leng. Mand. Linear 
Body (cm)
Right -0.13 ± 0.17 -0.90 ± 0.25 NS
Left -0.10 ± 0.21 -0.06 ± 0.15 NS
Total hemimandibu-
lar length
Right -0.08 ± 0.31 -0.07 ± 0.27 NS
Left 0.02 ± 0.20 -0.07 ± 0.23 NS
Vol. Condyle (cc)
Right 0.01 ± 0.07 -0.20 ± 0.28 NS
Left 0.02 ± 0.46 -0.09 ± 0.25 NS
Vol. Ascending 
Branch (cc)
Right -0.79 ± 2.73 -0.51 ± 3.28 NS
Left -0.92 ± 3.44 -0.39 ± 2.83 NS
Vol. Mand. Body (cc)
Right -0.96 ± 3.88 -1.48 ± 3.28 NS
Left -0.63 ± 3.20 -0.72 ± 2.76 NS
Total mandibular 
volume
Right -1.74 ± 6.53 -2.19 ± 6.63 NS
Left -1.53 ± 6.17 -1.21 ± 5.81 NS
Table 2 cont.: Change in controlled variables during the 18-month follow-up period of the study (Postural symmetry, the only measurement 
for the craniofacial relation, is the difference in angles (left and right) formed by a plane from the zygomatic suture to the antegonion and the 
antegonion to the zygomatic arch).
Discussion
According to the published literature, a difference in 
scintigraphic uptake between condyles greater than 10% 
is a pathognomonic data for the detection of UCH activ-
ity, and this is the value we have used to determine our 
distribution of subjects in the study group (supposedly 
affected by active UCH) and the control group (suppos-
edly with no activity) (7). Saridin et al. studied SPECT 
findings in patients with condylar hyperplasia with and 
without progression of facial asymmetry (n=26 in each 
group) and concluded that the best data for identifying 
each group of patients was the comparison of condy-
lar hyperactivity between both condyles (13). Likewise, 
they carried out a meta-analysis on the published litera-
ture concluding that condylar uptake difference consid-
ered normal is less than 10% (14).
Various authors have corroborated setting condylar up-
take difference at 10% (15,17,23,24). However, Kajan et 
al. studied 38 patients, with an age range between 13 
and 34 years, using SPECT, giving a lower percentage 
in condylar uptake difference of healthy patients and 
those affected with UCH, concluding that the maximum 
variation in uptake between both healthy condyles in 
a patient without mandibular hyperplasia is 6.2% (12).
However, the data obtained in our study shows how this 
difference in uptake does not ensure the active devel-
opment of the disease, even in patients with complete 
bone maturation in accordance with Björk’s stages. At 
the beginning of the study, we performed this test to 
establish two groups according to UCH activity and we 
established as the study group those patients with scin-
tigraphic uptake difference greater than 10%. However, 
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after an 18-month follow-up of the study group patients 
there has been no evolution in their development of 
UCH, there being no statistically significant differences 
in any of the parameters studied, consequently we can 
state that these results suggest that stability in facial 
asymmetry in patients with complete bone maturation is 
not related to uptake difference between both condyles.
Robinson et al. published a study in 1990 with simi-
lar results to ours with another type of scintigraphy to 
carry out the diagnosis, planar scintigraphy, since they 
detected persistence in condylar uptake in the study in 
6 of 10 patients with clinically inactive UCH (19). Hen-
derson et al. obtained similar results in their study of 
14 patients with UCH (18). These authors found that an 
increased unilateral uptake of the radioisotope in planar 
scintigraphy could often indicate abnormal active con-
dylar growth. However, they determined that the false 
positives could be found in patients with TMJ diseases 
giving altered results in scintigraphy (18,25).
After these results, many authors  published that the 
diagnosis made using SPECT replaced to a greater ex-
tent planar scintigraphy in the evaluation of growth in 
mandibular asymmetry due to the fact that it is a more 
reliable technology and without limitations in the po-
sitioning of the patient or overlapping with other bone 
structures, finding a condyle uptake percentage related 
to the 55% indicative of activity (11). Chan et al. com-
pared planar scintigraphy with SPECT in 23 patients 
with UCH and 16 healthy subjects, finding an uptake 
difference between normal condyles of 7% in SPECT 
and 5% in planar scintigraphy (10), and determining 
that the use of SPECT was the technology of choice in 
the diagnosis of UCH activity and being corroborated 
by various authors (26-30), who furthermore concluded 
that the sensitivity of SPECT is between 88 and 95% 
and specificity between 61.1 and 77% (29,30).
However, as we have mentioned earlier, the fact that 
there is a condylar uptake difference greater than 10% 
does not imply the development and advance of the dis-
ease. To do so, we have compared data with orthodontic 
parameters during the 18 months of the study in each 
individual, and we have compared the data obtained, 
not finding any statistically significant difference be-
tween both temporal points. Hodder et al. in the year 
2000 studied 18 patients with UCH and 11 control sub-
jects and although they considered abnormal a relative 
uptake percentage in SPECT of the condyle affected 
greater or equal to 55%, they added that the diagnosis 
of condylar activity must be associated with a clinical, 
cephalometric and x-ray evaluation of the patient for 
therapeutic decision making, since in all cases there 
was no development or advance in UCH (16). The re-
sults obtained in our study and others such as that of 
Hodder et al. may be as such because SPECT results 
are only a snapshot of the relative growth rate between 
condyles at a given time as Karssemakers et al. stated 
(16,20). These authors concluded that the diagnosis of 
UCH activity should be based on the combined use of 
SPECT and the clinical history of the patient in order 
to avoid erroneous diagnoses resulting from obtaining 
results at a specific time of a dynamic process such as 
growth (20).
Conclusions
After implementing this study, we can conclude that the 
differential percentage in uptake of the mandibular con-
dyles in scintigraphy is not a valid diagnostic method 
for predicting the evolution of patients with unilateral 
condylar hyperplasia. The use of CT scans and the tak-
ing of measurements of mandibular condyle volume, 
mandibular ascending branch, mandibular body and 
total hemimandible are valid diagnostic data in the de-
tection and control of the evolution of patients with uni-
lateral condylar hyperplasia.
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